AbCellera Biologics (ABCL) Prepaid Assets (2020 - 2026)

AbCellera Biologics has reported Prepaid Assets for 7 years, with the latest figure at $98.1 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 3.59% year-over-year to $98.1 million; the trailing twelve-month figure through Mar 2026 stood at $98.1 million (up 3.59% YoY), and the FY2025 full-year result was $111.1 million, up 65.49% from the prior year.
• Prepaid Assets for Q1 2026 stood at $98.1 million, down from $111.1 million in the prior quarter.
• The five-year high for Prepaid Assets was $133.0 million in Q3 2025, with the low at $28.9 million in Q1 2022.
• Historically, Prepaid Assets has averaged $73.3 million across 5 years, with a median of $67.1 million in 2024.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 600.81% — and 2024, when it slumped 43.01%.
• AbCellera Biologics' Prepaid Assets stood at $75.4 million in 2022, then slipped by 25.99% to $55.8 million in 2023, then climbed by 20.3% to $67.1 million in 2024, then jumped by 65.49% to $111.1 million in 2025, then dropped by 11.71% to $98.1 million in 2026.
• The last three Prepaid Assets figures came in at $98.1 million (Q1 2026), $111.1 million (Q4 2025), and $133.0 million (Q3 2025), per Business Quant data.